Loading insider details...
Latest Form 4 (Nov 5, 2026): Exercise/Conversion of 1,199 MNPR shares, $36.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,199 | $36.0K |
| Aug 29, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,055 | $61.6K |
| Dec 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 2,924 | n/a |
| Jul 17, 2025 | Monopar Therapeutics (MNPR) | In-the-Money Exercise | 8,904 | $44.52 |
| Mar 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 11,365 | n/a |
| Jul 2, 2024 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 9,957 | n/a |
| Apr 3, 2024 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 9,956 | n/a |
| Jan 4, 2024 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 9,957 | n/a |
| Oct 3, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 9,956 | n/a |
| Jul 3, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 14,846 | n/a |